Sounds very interesting. Is this a directed differentiation approach and do you have any issues with off target differentiation?
What hurdles do you need to overcome if you do manage to produce on a scale to introduce this as a therapeutic option (e.g. regulatory)?
Is the risk of mycoplasma contamination a concern in culturing this for use?
ravioliraviolii t1_iumur69 wrote
Reply to We’re Sandhya Moise, David Phillips and Chan Lee from the Department of Chemical Engineering at the University of Bath in the United Kingdom. Our research aims to grow human red blood cells in the lab to help treat cancer and other diseases. by UniversityofBath
Sounds very interesting. Is this a directed differentiation approach and do you have any issues with off target differentiation?
What hurdles do you need to overcome if you do manage to produce on a scale to introduce this as a therapeutic option (e.g. regulatory)? Is the risk of mycoplasma contamination a concern in culturing this for use?